Skip to content

Effects of Multimodal Treatment of Headache in a Day Clinic Service

Effects of Multimodal Treatment of Headache in a Day Clinic Service: a Prospective Case-crossover Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05111873
Enrollment
50
Registered
2021-11-08
Start date
2021-02-15
Completion date
2022-05-30
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache Disorders

Keywords

multimodal treatment, quality of life, day clinic service

Brief summary

The observational study aims to investigate the effects of a multimodal treatment program for headache patients in a day clinic service. The setting provides one week of treatment including a combination of medical consultation, physiotherapy, psychological therapy, occupational therapy, progressive muscle relaxation and disease specific education. Outcome measures are the disease-specific impact on daily activities, general quality of life, psychological impact and headache frequency. Moreover, the study sought to identify parameters that best predict efficacy of the intervention. Therefore, standardized questionnaires are established in three points in time, to evaluate the pre- and post-treatment status.

Detailed description

duration of treatment: 5 days; first questionnaire (V0): minimal 4 weeks prior to the treatment appointment; second questionnaire (V1): on the first day of the treatment program; third questionnaire (V2 / Follow up): 3 month (+- 6 weeks) after finishing the treatment; data collection through patient self-report; Follow-up via mail

Interventions

combination of medical consultations, psychological therapy, physiotherapy, occupational therapy, disease specific education und progressive muscle relaxation

Sponsors

University Medicine Greifswald
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosis of a headache disorder * written informed consent for collecting and analysing data and conducting a follow-up evaluation

Exclusion criteria

* premature interruption of the treatment * repeated treatment

Design outcomes

Primary

MeasureTime frameDescription
Change of Veterans RAND 12 Item Health Survey (VR-12) mental health score4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentquestionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10

Secondary

MeasureTime frameDescription
Change of Depression Anxiety and Stress Scale (DASS)4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentquestionnaire, patient self-report, 21 questions, 7 questions per subscale (Depression, Anxiety and Stress), minimum value: 0 points, maximum value: 21 points per subscale, higher score = worse outcome
Change of Headache Impact Test (HIT6)4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentquestionnaire, patient self-report, minimum value: 36 points, maximum value: 78 points, higher score = worse outcome
Change of Headache frequency4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentin days per month, referring to the last month, minimum value: 0 days/month, maximum value: 30 days/month
Change of Veterans RAND 12 Item Health Survey (VR-12) physical health score4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentquestionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10
Change of Pain intensity4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentaverage pain intensity in the last month, scale 1 to 10, higher score = worse outcome

Other

MeasureTime frameDescription
Change of Veterans RAND 12 Item Health Survey (VR-12) single domains4 weeks prior to treatment appointment, day 1 of treatment, 3 month after the treatmentquestionnaire, patient self-report, 12 questions, minimum value: 12 points, maximum value: 54 points, physical and mental health component summary score compared to a t-score with a mean value of 50 and standard deviation of 10

Countries

Germany

Contacts

Primary ContactRobert Fleischmann, MD
robert.fleischmann@uni-greifswald.de+493834866778

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026